Show notes
This week's top stories in Cardiology.
- Updated systematic review of aspirin primary prevention shows benefits, risks
- GLP-1 RA dulaglutide yields cardiac gains, even in non–at-risk patients
- DOACs surpass warfarin in low-weight AFib patients
- Medicaid expansion associated with lower cardiovascular mortality
You can email the show at [email protected].



